Abortion Pill Cases Test Whether FDA Rules Preempt State Limits

“The relationship between the FDA’s regulatory power and the state’s power to regulate the practice of medicine is a complicated one,” Professor Wendy Parmet tells Bloomberg Law. “And the FDA’s involvement in mifepristone is much more complex than with most medications.”